2021
DOI: 10.1080/08820139.2021.1909616
|View full text |Cite
|
Sign up to set email alerts
|

Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 49 publications
0
4
0
Order By: Relevance
“…In the subacute treatment setting, miR-218-5p was significantly upregulated at the end point, which is in agreement with decreased dopaminergic neuron loss in Parkinson’s disease patients due to miR-218-5p targeting LASP1 [ 56 ]. In contrast, downregulation of miR-218-5p has been associated with increased inflammatory response in patients with multiple sclerosis [ 57 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In the subacute treatment setting, miR-218-5p was significantly upregulated at the end point, which is in agreement with decreased dopaminergic neuron loss in Parkinson’s disease patients due to miR-218-5p targeting LASP1 [ 56 ]. In contrast, downregulation of miR-218-5p has been associated with increased inflammatory response in patients with multiple sclerosis [ 57 ].…”
Section: Discussionmentioning
confidence: 99%
“…There, a neuronal cell model for acute ischemic stroke was used to reduce inflammatory cytokine secretion, oxidative stress, cell apoptosis and maintenance of endovascular homeostasis via upregulating NDRG4. Several diagnostic miRNA markers for spinal cord injury have already been described in the literature [ 57 , 61 , 68 , 93 , 94 , 95 , 96 ]. In our study, we found miR-218-5p, miR-199a-3p, miR-29c-3p, miR-133b to be similarly up- or downregulated following spinal cord injury.…”
Section: Discussionmentioning
confidence: 99%
“…Mosarrezaii Aghdam et al reported an association of miR‐125a‐5p and miR‐218‐5p with disease pathogenesis. 26 Myasthenia gravis (MG) is a neuromuscular disease that results in skeletal muscle weakness. Although the determination of serum antibodies of acetylcholine receptor (AChR+) or muscle‐specific tyrosine kinase (MuSK+) is often insufficient to reflect disease progression, the development of a reliable biomarker panel would help to understand disease progression.…”
Section: Mirna and Disease Associationmentioning
confidence: 99%
“…Numerous studies have confirmed that miRNAs are valuable pathological and diagnostic prognostic markers. Mosarrezaii Aghdam et al reported an association of miR‐125a‐5p and miR‐218‐5p with disease pathogenesis 26 . Myasthenia gravis (MG) is a neuromuscular disease that results in skeletal muscle weakness.…”
Section: Mirna and Disease Associationmentioning
confidence: 99%